EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE

QR Code

EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE

the present review is devoted to an actual problem of safety of pharmacotherapy in clinical practice; the particular attention is paid to the state of this problem in pediatrics. Information about pharmacovigilance is proposed; criteria of definition, methods of collecting (their advantages and limi...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. N. Kostyleva, Yu. B. Belousov, A. N. Gratsianskaya, S. S. Postnikov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2015-03-01
Series:	Фармакоэкономика
Subjects:	safety of pharmacotherapy adverse drug reactions monitoring of drug safety pediatrics pharmacovigilance methods of pharmacovigilance clinical pharmacologist off label use of drugs
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/57
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of Pharmacovigilance in Drug Safety Monitoring
by: Anju E. Paul, et al.
Published: (2025-07-01)

International Drug Safety Monitoring
by: A. S. Kazakov, et al.
Published: (2019-09-01)

Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
by: N. V. Molchan, et al.
Published: (2019-06-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
by: S. K. Zyryanov, et al.
Published: (2020-05-01)

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
by: N. Yu. Velts, et al.
Published: (2018-09-01)

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025
by: V. I. Petrov
Published: (2025-01-01)

Results of Surveying Cardiologists and Clinical Pharmacologists on the Selection and the Efficacy and Safety Evaluation of Pharmacotherapy for Cardiovascular Diseases
by: Yu. R. Bolsunovskaya, et al.
Published: (2022-12-01)

Off-Label Prescribing in Paediatric Cardiology: Regulatory Aspects and Safety Assessment by Spontaneous Reporting
by: E. O. Kochkina, et al.
Published: (2023-03-01)

Recommendations on Informational Monitoring of the Safety and Efficacy of Medicinal Products in the Russian Federation as Part of Pharmacovigilance
by: K. S. Milchakov
Published: (2022-10-01)

Topical Issues of Drug Safety, Possibilities of Improving of Pharmacovigilance
by: M. V. Zhuravleva, et al.
Published: (2019-09-01)

What is the role of antineoplastic drug safety in reimbursement decision making?
by: A. S. Kolbin, et al.
Published: (2018-11-01)

Aspects of the Safe Use of Antibacterial Drugs in Community-Acquired Pneumonia: the Implications of Drug-Drug Interactions
by: A. A. Taube, et al.
Published: (2022-08-01)

DRUG SAFETY MONITORING SERVICE IN DEVELOPING ORGANIZATIONS / MANUFACTURERS OF DRUGS FOR VETERINARY USE
by: N. P. Biryukova, et al.
Published: (2019-09-01)

The Adverse Drug Reactions Registered During the Postmarketing Period
by: E. V. Shubnikova, et al.
Published: (2019-03-01)

Safety of the Off-Label Use of Antitumor Drugs in Real Clinical Practice: Experience of Oncologists of the Russian Federation
by: E. V. Каrabina, et al.
Published: (2024-12-01)

MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE
by: N. V. Verlan, et al.
Published: (2017-02-01)

Problematic aspects of participation of pharmacists in the system of pharmacovigilance in Russia
by: E. N. Tkhoseva, et al.
Published: (2022-06-01)

“Implementing the pharmacovigilance system and publishing this journal, we were helping healthcare providers cultivate the sense of professional and civic responsibility”
by: V. K. Lepakhin, et al.
Published: (2024-04-01)

Comparative Analysis of Drug Interactions with Antibacterial Agents in the Treatment of Community-Acquired Pneumonia
by: A. A. Taube, et al.
Published: (2021-10-01)

Analysis of pharmacy organisation staff awareness of pharmacovigilance
by: R. I. Yagudina, et al.
Published: (2025-06-01)

Drug Safety Monitoring—International Information
by: E. V. Shubnikova, et al.
Published: (2020-12-01)

Safety of Antibacterial and Antiprotozoal Medicinal Products
by: E. V. Shubnikova, et al.
Published: (2022-07-01)

Current Information on the Safety of Medicinal Products: Decisions of Foreign Regulatory Authorities
by: E. V. Shubnikova
Published: (2024-04-01)

Retrospective Analysis of Spontaneous Reports of Fatal Adverse Reactions Associated with Lidocaine
by: A. V. Matveev, et al.
Published: (2024-04-01)

Analysis of the decisions of foreign regulatory authorities
by: Relevant information
Published: (2019-06-01)

IS THE PATIENT PARTNERSHIP INFORMATIVE IN PHARMACOVIGILANCE?
by: Yu. V. Muravyev
Published: (2017-09-01)

Off-Label Drug Use in Pediatric Practice: Unsolved Problems
by: A. R. Titova, et al.
Published: (2015-10-01)

Clinical and pharmacological monitoring of drug safety in pediatrics
by: N. V. Verlan, et al.
Published: (2016-05-01)

Postmarketing Surveillance: Review of Open Sources of Drug Safety Data
by: E. V. Shubnikova
Published: (2024-10-01)

Comparative Analysis of International Databases of Adverse Drug Reactions
by: A. S. Kazakov, et al.
Published: (2020-09-01)

Drug Safety Monitoring Information
by: E. V. Shubnikova, et al.
Published: (2021-07-01)

Review of publications on drug-related problems investigations in osteoporosis patients
by: E. A. Egorova, et al.
Published: (2024-01-01)

Analysis of Data on Adverse Drug Reactions and Functional Flaws of the Pharmacovigilance System Associated with Self-Treatment with Antibiotics
by: N. V. Verlan, et al.
Published: (2022-10-01)

Monitoring of Foreign Drug Safety Information
by: Editorial article
Published: (2019-12-01)

Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice
by: A. V. Matveev, et al.
Published: (2023-03-01)

Identification and Evaluation of Safety Signals of Drugs Currently under Development Using a Limited Data Set
by: B. K. Romanov, et al.
Published: (2019-12-01)

Safety of Off-Label Use of Anticancer Drugs in Oncology
by: E. V. Karabina, et al.
Published: (2024-04-01)

Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment
by: E. Yu. Demchenkova, et al.
Published: (2021-03-01)

Optimisation of Approaches to Adverse Event Analysis in Bioequivalence Clinical Trials
by: A. B. Verveda, et al.
Published: (2024-04-01)

Adverse Reactions of Drugs Containing Valeriana and Corvalol: Analysis of Spontaneous Reporting
by: S. L. Morokhina, et al.
Published: (2018-12-01)